Search results
Author(s):
Josep Rodés-Cabau
Added:
1 month ago
TCT 2025 - Short-term anticoagulation reduced adverse events following left atrial appendage closure (LAAC) compared to dual antiplatelet therapy (DAPT).Dr Josep Rodés-Cabau (Quebec Heart and Lung Institute, Quebec, CA) joins us at TCT 2025 to discuss findings from ANDES trial (NCT03568890) investigating the safety and efficacy of short-term anticoagulation versus DAPT for preventing device…
View more
Author(s):
Jeffrey Weitz
,
Davide Capodanno
Added:
3 months ago
Presented at the European Society of Cardiology (ESC) Congress 2025, Prof Carolyn Lam (Singapore, UK), Prof Davide Capodanno (Catania, IT), Dr Sneha Shah Jain (Stanford, US) and Prof Jeffrey Weitz (Hamilton, CA) examine the prevalence and challenges of stroke prevention in atrial fibrillation (AF) and after acute coronary syndrome (ACS). The faculty review current treatment guidelines, explore…
View more
Author(s):
Carolyn Lam
,
Jeffrey Weitz
Added:
3 months ago
Hear from Prof Carolyn Lam and Prof Jeffrey Weitz as they share key take-home messages from ESC 2025.Filmed onsite, this peer-to-peer discussion distils the latest updates in thrombosis management for acute coronary syndrome (ACS), secondary stroke prevention (SSP) and atrial fibrillation (AF).Register for the upcoming Q&A webinar, taking place on 6 October (14:00 EDT / 20:00 CEST), to put your…
View more
Author(s):
Carolyn Lam
,
Jeffrey Weitz
,
Sneha Shah Jain
Start date:
Oct 06, 2025
Following the ESC 2025 symposium 'Revolutionising Thrombosis Treatment in ACS, SSP and AF – Bridging the Gaps With Next Generation Anticoagulation Strategies', this live Q&A webinar offers an exclusive chance to continue the conversation.Join Prof Carolyn Lam (Singapore, UK), Prof Jeffrey Weitz (Hamilton, CA) and Dr Sneha Shah Jain (Stanford, US) as they address your questions on stroke…
View more
Added:
5 months ago
Source:
Radcliffe Cardiology
AUTHOR: Greg GuilloryThe selection of drug-eluting stents (DES) for percutaneous coronary intervention (PCI) involves balancing efficacy against safety. The SORT OUT XI randomised trial aimed to compare a newer-generation biolimus-eluting stent with a contemporary dual-therapy sirolimus-eluting stent in a real-world patient population, providing crucial head-to-head evidence.¹SORT OUT XI was a…
View more
Added:
3 months ago
Source:
Transcatheter Academy
For patients with symptomatic left-sided mechanical prosthetic valve thrombosis (PVT), the optimal treatment strategy between urgent surgery and fibrinolytic therapy (FT) has been uncertain. The SAFE-PVT trial, the first randomised controlled trial (RCT) to directly compare these approaches, found that while surgery is associated with a higher risk of complications and death, FT often results in…
View more
Stavros Konstantinides
Research Area(s) / Expertise:
Author
Expertise
Darko Antic
Job title: Professor of Internal Medicine
Author
Rita Paniccia
Job title: University Researcher
Author
Arina ten Cate-Hoek
Job title: Associate Professor of Medicine, FHML; Medical Director, Anticoagulation Clinic, Maastricht University Medical Center
Author